[XENE] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
09-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -25.20%
YoY- -130.37%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 7,078 0 0 16 601 4,010 5,001 5.95%
PBT -7,485 -11,304 -3,755 -7,517 -3,263 -4,225 1,373 -
Tax -1 37 159 -470 -2,395 3,019 -341 -62.13%
NP -7,484 -11,341 -3,755 -7,517 -3,263 -4,225 1,373 -
Tax Rate - - - - - - 24.84% -
Total Cost 14,562 11,341 3,755 7,533 3,864 8,235 3,628 26.03%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -105.74 0.00 0.00 -46,981.25 -542.93 -105.36 27.45 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.23 -0.44 -0.22 -0.42 -0.23 -0.30 0.15 -
EPS Diluted -0.23 -0.44 -0.21 -0.42 -0.23 -0.30 0.14 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.